DARMSTADT, Germany, Nov. 3, 2015 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced it was named one of the top 20 employers in the biopharmaceutical industry by Science magazine, a leading peer-reviewed international scientific publication. Merck KGaA, Darmstadt, Germany, ranked 17th among biotechnology and pharmaceutical companies worldwide. This is the second year in a row the Company has been named to the Top Employer list, improving from its position of number 20 in 2014. The biopharmaceutical business of Merck KGaA, Darmstadt, Germany, operates as EMD Serono in the United States.
Merck KGaA, Darmstadt, Germany, is proud of the innovation that exists within its R&D organizations across all business areas, and the commitment of employees to deliver that innovation to our stakeholders, including patients in need around the world. The people of Merck KGaA, Darmstadt, Germany, are fundamental to its success, and this recognition is a compliment to their dedication and contributions.
Each year, Science Careers commissions a survey to identify the top employers in the biotechnology and pharmaceutical industry and to determine the characteristics that best describe a top employer. This year, the results are based on 5,700 responses to a web-based survey deployed by e-mail.
In selecting the best companies, respondents yet again chose "innovative leader" as the top-driving characteristic. A top employer is also defined as an organization that "treats employees with respect," "has loyal employees," "is socially responsible," and has a "work culture aligned" with employees' values.
The 2015 survey included a way for respondents to rank the biggest advantages to working in the biopharma industry. Workers voted "innovation" solidly as #1, followed by "working with smart colleagues" and "excellent compensation and benefits" as a close #2 and #3, respectively.
Merck KGaA, Darmstadt, Germany, ranked highly across the categories of social responsibility, having loyal employees, and having a work culture aligned with employees' values.
Science Magazine's annual Top Employer feature became available in print and online October 29, 2015 and includes detailed survey results for the top 20 companies overall.
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany is a leading science and technology company in healthcare, life science and performance materials. Around 40,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2014, Merck KGaA, Darmstadt, Germany generated sales of € 11.3 billion in 66 countries.
Founded in 1668, Merck KGaA, Darmstadt, Germany is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany holds the global rights to the Merck KGaA, Darmstadt, Germany, name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, EMD Millipore and EMD Performance Materials.
About EMD Serono, Inc.
EMD Serono is the North America biopharma business of Merck KGaA, Darmstadt, Germany - a leading science and technology company - focused exclusively on specialty care. For more than 40 years, the business has integrated cutting-edge science, innovative products and industry-leading patient support and access programs. EMD Serono has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in oncology, immuno-oncology and immunology as R&D focus areas. Today, the business has more than 1,100 employees around the country with commercial, clinical and research operations based in the company's home state of Massachusetts.
CONTACT: Heather Connor, +1-978-294-1660
SOURCE Merck KGaA